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Abstract 
Background: The malaria burden in sub-Saharan Africa (SSA) has fallen substantially. Nevertheless, malaria remains 
a serious health concern, and Uganda ranks third in SSA in total malaria burden. Epidemiological studies of adult 
malaria in Uganda are scarce and little is known about rates of malaria in non-pregnant adult women. This pilot study 
assessed malaria prevalence among adult women from Wakiso district, historically a highly malaria endemic region.
Methods: Adult women using public health services were screened for malaria, HIV and pregnancy. A physician-
selected subset of women presenting to the Outpatient Department of Entebbe General Hospital (EGH) with current 
fever (axillary temperature ≥37.5 °C) or self-reporting fever during the previous 24 h, and a positive thick smear for 
malaria in the EGH laboratory were enrolled (n = 86). Women who self-identified as pregnant or HIV-positive were 
excluded from screening. Malaria infection was then assessed using HRP2/pLDH rapid diagnostic tests (RDTs) in all 
participants. Repeat microscopy and PCR were performed at a research laboratory for a subset of participants. In addi-
tion, 104 women without a history of fever were assessed for asymptomatic parasitaemia using RDT, and a subset of 
these women screened for parasitaemia using microscopy (40 women) and PCR (40 women).
Results: Of 86 women diagnosed with malaria by EGH, only two (2.3%) had malaria confirmed using RDT, subse-
quently identified as a Plasmodium falciparum infection by research microscopy and PCR. Subset analysis of hospital 
diagnosed RDT-negative participants detected one sub-microscopic infection with Plasmodium ovale. Compared 
to RDT, sensitivity, specificity and PPV of hospital microscopy were 100% (CI 19.8–100), 0% (CI 0–5.32) and 2.33% 
(CI 0.403–8.94) respectively. Compared to PCR, sensitivity, specificity and PPV of hospital microscopy were 100% 
(CI 31.0–100), 0% (CI 0–34.5) and 23.1% (CI 6.16–54.0), respectively. No malaria was detected among asymptomatic 
women using RDT, research microscopy or PCR.
Conclusions: Malaria prevalence among adult women appears to be low in Wakiso, but is masked by high rates of 
malaria overdiagnosis. More accurate malaria testing is urgently needed in public hospitals in this region to identify 
true causes of febrile illness and reduce unnecessary provision of anti-malarial therapy.
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Background
Although great progress has been made over the past 
one and a half decades in reducing the burden of malaria 
[1], the disease remains a leading cause of morbidity and 
mortality in sub-Saharan Africa (SSA). Because young 
children bear the brunt of malaria-associated morbidity, 
an understanding of the malaria burden in adults is frag-
mented and assessment of malaria control in this popula-
tion is needed [2–4]. Uganda ranked fourth globally and 
third in SSA in terms of the total malaria cases in 2015 
[5], but most epidemiological data until recently were 
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obtained from surveys in young children. The 2014–
2015 Malaria Indicator Survey, for instance, reported 
that the average prevalence of malaria was 30% (varying 
from 3.7 to 51.3% based on the region) in Ugandan chil-
dren aged 0–59 months as assessed using malaria rapid 
diagnostic tests (RDT) and 19% (0.4–36.2%) as assessed 
by light microscopy (LM) in the same age cohort [6]. A 
2011–2013 community-based survey conducted in three 
Ugandan sub-counties with varied transmission settings 
performed the first rigorous assessment of malaria met-
rics in both children and adults [7–9]. According to the 
results of this survey, malaria prevalence based on LM 
ranged from 3.0 to 5.1% among adults aged ≥18, while 
prevalence based on both LM and molecular techniques 
ranged from 18.8 to 53.5% in the same age group [8]. This 
is one of the first detailed studies on the prevalence of 
malaria in adults, but additional data from other regions 
and broad age groups is needed to adequately monitor 
malaria trends in Uganda [10].
Sub-Saharan Africa health facilities tend to over-diag-
nose malaria in patients presenting with symptoms such 
as fever, due to traditional perceptions (e.g. perceptions 
of high malaria endemicity and any fever being equiva-
lent to malaria) and issues related to laboratory test-
ing [11–14]. The gold standard for malaria diagnosis is 
microscopic examination of blood smears. However, 
maintaining high standards of LM requires multiple pre-
requisites, which are difficult to maintain in resource-
limited settings in SSA [15]. To aid parasite-based 
malaria diagnosis, RDTs have recently been incorporated 
into clinical guidelines of malaria-endemic countries [5]. 
RDTs that detect circulating Plasmodium antigens, his-
tidine-rich protein 2 (HRP2) and lactate dehydrogenase 
(pLDH), perform similarly well to expert LM, and can 
often exceed the quality of field LM in clinical studies [11, 
16–19]. Importantly, RDTs require minimal training and 
equipment, hence making them a feasible malaria-testing 
tool for primary care workers with limited laboratory 
experience.
The objective of this pilot study was to assess malaria 
prevalence among adult women with and without a 
history of fever, who were accessing public health ser-
vices in Entebbe, Wakiso district, Uganda. Historically, 
Entebbe has been classified as a malaria hyper-endemic 
area [20, 21] with an estimated malaria prevalence of 
13% in young children [6]. Most studies of malaria 
rates in adults in the region have focused on preg-
nant women or HIV-infected persons [22–24] and 
as a result the effectiveness of recent interventions in 
reducing malaria prevalence in the general population 
is unknown. An HRP2/pLDH RDT was used to screen 




Entebbe is located in Central Uganda (Fig. 1). This region 
is a peninsula in Lake Victoria inhabited by semi-urban, 
rural and fishing communities. Rainfall patterns in 
Entebbe are bimodal with rainy seasons in March–May 
and in September–November, and peak malaria trans-
mission tends to occur several weeks after the end of the 
rainy season [6, 20]. Malaria infection in this region is 
caused primarily by Plasmodium falciparum, but infec-
tion by Plasmodium malariae and Plasmodium ovale has 
also been observed [6]. Entebbe General Hospital (EGH) 
Outpatient Department (OPD) offers government-subsi-
dized services to the residents of Entebbe town and of the 
peri-urban communities surrounding Entebbe.
Participant characteristics
As a precursor to studies on the immune impact of 
malaria infection, women aged 18-45 years were screened 
for malaria, HIV and pregnancy between July-December 
2015 (see below and Table 1). A physician-selected sub-
set of women presenting to the EGH OPD with fever 
(axillary temperature ≥37.5  °C) or a self-report of fever 
during the previous 24 h, and a positive thick smear for 
malaria in the EGH laboratory were enrolled (n  =  86; 
Fig.  2; Table  1). Women who self-identified as pregnant 
or HIV-positive were excluded from screening.
Malaria LM is one of the most frequently requested 
laboratory tests at EGH. During the study period, the 
EGH laboratory staff rotated on a weekly basis and a total 
of three technicians performed blood smear analysis. 
On any given day, only one microscopist was at the LM 
bench. Individuals diagnosed with malaria by the EGH 
clinician received artemisinin-based combination ther-
apy (ACT) and/or quinine according to the Uganda clini-
cal guidelines. HIV rapid testing was conducted using the 
Uganda Ministry of Health testing algorithm [25]. Preg-
nancy was tested using QuickVue One-Step hCG urine 
test (Quidel Corporation, USA).
RDT screening
Malaria infection was then assessed using RDT in all 
participants. At all sites, two RDTs meeting the WHO 
performance criteria [26] were employed to detect a P. 
falciparum or mixed Plasmodium species infection. The 
First Response Malaria Ag pLDH/HRP2 (Premier Medi-
cal Corp Ltd, India), validated by previous studies from 
Uganda, India and Yemen to have high performance char-
acteristics [19, 27, 28], was used on all participants, and 
the SD Bioline Malaria Ag Pf/Pan (Standard Diagnostics 
Inc, South Korea), previously validated for routine use at 
the UVRI-IAVI HIV Vaccine program, was also used to 
retest 10% of samples for quality control. RDT kits were 
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stored at room temperature as recommended by the 
manufacturer. Study personnel were trained in the safe 
use and interpretation of the RDT following the manu-
facturer’s instructions. Approximately 5 μl of capillary or 
venous blood was tested and results were read and inter-
preted within 20 min. RDT results were considered valid 
only if the control test line was positive.
Repeat LM and PCR testing
Confirmatory thick and thin smear LM analysis was 
performed for a subset of participants (n  =  16) at the 
UVRI-IAVI HIV Vaccine Programme’s research labora-
tory as follows. Blood was transported to the research 
laboratory, where two blinded microscopists prepared 
thick and thin blood films using Field stain and separately 
performed LM. A blood film was considered negative if 
no parasites were detected after 100 high power fields 
had been examined. If parasites were observed, counting 
was performed against 200 white blood cells on the thick 
film. The thin film was used for malaria species identifi-
cation and known positive/negative samples were used 
as test controls. Discrepant LM results were resolved by 
the UVRI Medical Research Council Clinical Diagnos-
tics Lab Services (MRC/UVRI CDLS). The UVRI-IAVI 
Fig. 1 Map of Uganda showing the location of the study site (Entebbe, Wakiso District). The map was created using an online tool SimpleMappr 
[40]
Table 1 Clinical characteristics of study participants
Parameter Fever group No fever group
Age: median (range) 25 (18–45) 29 (18–45)
RDT-positive 2.3 (2/86) 0 (0/104)
HIV-positive % 2.3 (2/86) 4.8 (5/104)
Pregnant % 20.9 (18/86) 3.8 (4/104)
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research microscopists receive extended practical train-
ing in malaria parasitology and LM at MRC/UVRI CDLS 
and participate in quarterly inter-laboratory comparisons 
with the MRC/UVRI CDLS experts. In the last three 
years, the UVRI-IAVI research laboratory has also partic-
ipated with satisfactory performance in the Royal College 
of Pathologists of Australasia (RCPA)-Malaria External 
Quality Assurance Programme.
For PCR investigation, dried blood spots (DBS) were 
prepared by blotting blood onto Whatman FTA cards 
(GE Healthcare, UK) kept at room temperature until 
DNA extraction. Nested Plasmodium spp.-specific PCR 
was then performed at the University of Toronto, as 
described elsewhere [29] on thirteen participants that 
had a repeat LM result.
Screening for asymptomatic malaria
To assess malaria prevalence among asymptomatic indi-
viduals, women without a history of fever (n = 104) who 
were attending the family planning or child vaccination 
clinics at either the Mother and Child Health (MCH) 
department of EGH or the Uganda Virus Research Insti-
tute (UVRI) outpatient clinic were enrolled for malaria 
screening using RDT. In addition, a randomly chosen 
set of 40 women underwent thick and thin smear LM at 
UVRI-IAVI and another set of 40 participants was tested 
using nested PCR.
Results
Among 86 OPD women with fever or a history of fever 
and a positive blood thick smear as reported by the 
EGH laboratory, approximately 20% were pregnant and 
2% were HIV-infected (Table  1). Only 2.3% (2/86) were 
positive on the RDT; these women were 24 and 30 years 
old and were not pregnant or HIV-infected. Of the 84 
women with a clinical diagnosis of malaria but a nega-
tive RDT, confirmatory LM testing was performed for 
14 participants, as well as for both RDT-positive par-
ticipants (Fig. 2). Additionally, PCR was performed on a 
subset of thirteen samples (both RDT-positive and nine 
RDT-negative samples). RDT-positive samples were con-
firmed by both research (UVRI-IAVI) LM and by PCR as 
P. falciparum positive. Out of fourteen participants that 
had been initially scored positive by the EGH laboratory, 
none were scored positive by research LM. In a subset of 
eleven RDT-negative participants that were also scored 
negative by research LM, one sample was positive for 
P. ovale by PCR (Fig.  2). Performance characteristics of 
hospital LM and RDT are summarized in Table 2. Com-
pared to RDT, sensitivity, specificity and PPV of hospital 
Fig. 2 Left panel diagnostic algorithm for adult women with suspected malaria at the outpatient department (OPD) of Entebbe General Hospital 
(EGH). Right panel diagnostic algorithm for adult afebrile women attending outpatient clinics at EGH and the Uganda Virus Research Institute (UVRI). 
RDT malaria rapid diagnostic test
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LM were 100% (CI 19.8–100), 0% (CI 0–5.32) and 2.33% 
(CI 0.403–8.94) respectively. Compared to research LM, 
sensitivity, specificity and PPV of hospital LM were 100% 
(CI 19.8–100), 0% (CI 0–26.8) and 12.5% (CI 2.20–39.59), 
respectively. Compared to PCR, sensitivity, specificity 
and PPV of hospital LM were 100% (CI 31.0–100), 0% 
(CI 0–34.5) and 23.1% (CI 6.16–54.0), respectively. Sen-
sitivity, specificity and PPV of RDT compared to research 
LM were 100% (CI 19.8–100), 100% (CI 73.2–100) and 
100% (CI 19.8–100), respectively. Compared to PCR, 
sensitivity, specificity and PPV of RDT were 66.7% (CI 
12.5–98.2), 100% (CI 65.5–100) and 100% (CI 19.8–100), 
respectively.
The prevalence of HIV in the asymptomatic group of 
104 women was 4.8% and 3.8% were pregnant (Table 1). 
No malaria was detected among these women using 
RDT, and in two randomly chosen subsets by research 
LM (40 individuals) or PCR (40 individuals) (Fig. 2).
Discussion
Overall, this study found high rates of malaria overdiag-
nosis and overtreatment at a major public health facility 
in Uganda. Most blood smears reported as positive by 
the hospital laboratory were not confirmed using RDT 
(97%) nor in a smaller sample subset, by research LM 
(88%) or PCR (77%). Overall, hospital LM had high sen-
sitivity (100%), but very low specificity and positive pre-
dictive values compared to RDT, research LM and PCR 
(Table  2). This reinforces well-described difficulties in 
the LM-based diagnosis of malaria in the public health-
care sector [11, 15, 30]. RDTs have been proposed as a 
feasible and more accurate alternative to LM in resource-
limited settings [11, 16, 17] and multiple SSA studies 
report reduction in antimalarial drug prescription after 
RDT implementation [18, 31, 32], further strengthening 
the incentive for RDT use in clinical practice. However, 
RDTs had been under-utilized by the EGH laboratory 
personnel due to irregular supply and lack of confi-
dence in RDT-based results. Based on the findings pre-
sented here, a more rigorous quality control programme 
is already being implemented for blood smear LM at the 
EGH laboratory, and the regular use of RDT in routine 
practice is being mandated.
Importantly, a very high false-positive rate of malaria 
diagnosis would be expected to lead to substantial 
malaria overtreatment, with the ensuing possibility of 
adverse drug effects, as well as under-management of 
other potentially important clinical causes of fever in the 
OPD. In agreement with the latter, SSA clinical studies 
found a higher case fatality rate among hospital patients 
misdiagnosed with malaria, compared to true malaria 
cases [12]. In addition, over-prescription of malaria 
drugs has implications for the emergence of parasite drug 
resistance, an important global concern [33]. Despite all 
this, malaria overdiagnosis remains a well-documented 
yet persistent issue in SSA resulting in over-inflation of 
actual malaria rates reported at the local and national 
levels [11–14].
Recent data regarding adult malaria prevalence rates in 
SSA and Uganda are limited [3, 4], as most malaria sur-
veys focus on the infection in children (e.g., [6, 9, 34]). 
In 2008, a survey performed in the Tororo district of 
eastern Uganda found a malaria prevalence of 10–20% 
among adult women, with the highest prevalence in 
younger women [35]. On the other hand, data extracted 
from the UVRI Clinic’s malaria testing records between 
2014 and 2016 show RDT positivity rates for febrile adult 
women from Entebbe of 6.3% (61/975), and the rate for 
the period overlapping the study reported here (July–
December 2015) was 6.2% (13/211; Miiro G and Drajole, 
D A, pers comm). These lower rates are more similar to 
the rates reported here, and may reflect geographic vari-
ation as well as the impact of local bed net programmes, 
rapid urbanization [34] and education about malaria pre-
vention practices [36]. Interestingly, RDT positivity rates 
reported by the UVRI clinic for men aged 18–45 were 
higher than in women [2014–2016 rate = 12% (74/628), 
July–December 2015 = 8.5% (9/106)], reflecting gender-
specific differences in malaria rates previously observed 
in other SSA studies [3, 35].
In the most recent survey from three sub-counties 
(Walukuba and Nagongera, both in Jinja district, Eastern 
Table 2 Performance of hospital LM (compared to RDT, research LM and PCR) and RDT (compared to PCR)
a Only malaria–diagnosed subjects were included in the study, hence the true estimate for this value is unknown. PPV positive predictive value
Diagnostic comparison True+ True− False+ False− Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI)
EGH LM vs. RDT 2 0a 84 0 100.0 (19.8–100) 0 (0–5.32)a 2.33 (0.403–8.94)
EGH LM vs. research LM 2 0a 14 0 100.0 (19.8–100) 0 (0–26.8)a 12.5 (2.20–39.59)
EGH LM vs. PCR 3 0a 10 0 100.0 (31.0–100) 0 (0–34.5)a 23.1 (6.16–54.0)
RDT vs. research LM 2 14 0 0 100.0 (19.8–100) 100 (73.2–100) 100 (19.8–100)
RDT vs. PCR 2 10 0 1 66.7 (12.5–98.2) 100 (65.5–100.0) 100 (19.8–100)
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Uganda and Kihini in Kanungu district, Southwestern 
Uganda) LM-based rates among adults peaked at 5.0%. 
The survey also uncovered six to tenfold higher rates of 
parasitaemia using a combination of LM and molecular 
techniques, highlighting high levels of previously unap-
preciated sub-microscopic parasitaemia [8]. In this study 
asymptomatic women did not have parasitaemia detecta-
ble by RDT, LM or PCR, implying that malaria rates may 
be low in the population. However this should be inves-
tigated further in a larger sample of symptomatic and 
asymptomatic adults.
The RDT used in this study had high sensitivity and 
specificity compared to research LM, but lower sen-
sitivity compared to PCR (Table  2), which detected P. 
ovale DNA in a sample scored negative by both research 
LM and RDT. This highlights an important limitation 
of RDTs- their low sensitivity for detection of P. ovale 
and P. malariae infections [37], which are implicated 
in ≈9.1% of malaria cases identified in the Central region 
of Uganda [6]. It is plausible that up to 9% of the febrile 
outpatients had patent P. ovale or P. malariae infections 
that were identified by the hospital microscopists but 
were not flagged by the RDT. Interestingly, the P. ovale 
PCR-positive individual was scored negative by research 
LM, implying that the patient had sub-microscopic para-
sitaemia. Sub-microscopic malaria is often not associated 
with clinical symptoms [9, 38], and hence was not a likely 
cause of fever in the majority of malaria-diagnosed RDT-
negative outpatients.
The findings presented here have limitations. First, this 
study was designed as a pilot to explore the prevalence 
of malaria among febrile outpatients and was intended 
neither to be a true malaria survey of the population nor 
a rigorous comparison of different malaria diagnostics. 
Rather, the study relied primarily on a previously vali-
dated RDT for malaria screening. The RDT’s validated 
high sensitivity for P. falciparum ensured detection of a 
majority of symptomatic malaria cases, however a minor-
ity of cases consisting of P. ovale and P. malariae would 
have been missed by the test. RDTs also tend to be less 
reliable at low parasite density settings, where PCR 
testing is recommended to confirm RDT performance 
[37]. However, DBS samples were not available from all 
study participants to assess the prevalence of sub-patent 
malaria by PCR among the febrile outpatients. Currently 
there are no standardized methods available for direct 
quality control of RDT performance in the field. There-
fore indirect methods, such as another RDT (SD Bioline), 
LM and PCR were used in this study to confirm the First 
Response RDT results. It was not possible to establish 
the impact each hospital microscopist had on the over-
all performance of EGH microscopy, which probably 
varied depending on individual expertise [30]. Data were 
not collected on recent self-medication with antima-
larial drugs, which would also have impacted the diag-
nostic accuracy of malaria tests. Lastly, since up to 80% 
of febrile individuals in Uganda seek treatment outside 
public health facilities [39], recruitment of febrile women 
through the OPD could have led to under-estimation 
of malaria as a cause for febrile illness in the district. 
Intriguingly, a larger proportion of febrile RDT-negative 
women (20.9%) had unsuspected pregnancy compared to 
asymptomatic women by HCG test (3.8%, Table 1). The 
implication of this finding is unclear and should be inves-
tigated in future studies.
Conclusions
In summary, a lower than anticipated prevalence of 
malaria was detected among adult women in Entebbe, 
Wakiso district and high rates of malaria overdiagno-
sis by LM were observed in a local public health facility. 
This confirms previously described difficulties in the LM-
based diagnosis of malaria, and emphasizes the impor-
tance of regular quality control and RDT use to avoid 
misdiagnosis and mistreatment of fever. These findings 
may not be uncommon in other regions of Uganda and 
SSA, where successful reductions in malaria transmis-
sion may be masked by sub-optimal diagnostic practices 
leading to over-inflation of perceived malaria burden. In 
many regions, malaria in pregnant women and children 
remains a major public health problem and more efficient 
allocation of resources for treatment and eradication of 
this infection may be urgently needed. This pilot study 
provides background for future more detailed investiga-
tions of malaria dynamics in Wakiso.
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